Is type II diabetes mellitus a disease of the innate immune system?
- PMID: 9794114
- DOI: 10.1007/s001250051058
Is type II diabetes mellitus a disease of the innate immune system?
Abstract
Type II (non-insulin-dependent) diabetes mellitus is associated with increased blood concentrations of markers of the acute-phase response, including sialic acid, alpha-1 acid glycoprotein, serum amyloid A, C-reactive protein and cortisol, and the main cytokine mediator of the response, interleukin-6. The dyslipidaemia common in Type II diabetes (hypertriglyceridaemia and low serum levels of HDL cholesterol) is also a feature of natural and experimental acute-phase reactions. We review evidence that a long-term cytokine-mediated acute-phase reaction occurs in Type II diabetes and is part of a wide-ranging innate immune response. Through the action of cytokines on the brain, liver, endothelium, adipose tissue and elsewhere, this process could be a major contributor to the biochemical and clinical features of metabolic syndrome X (glucose intolerance, dyslipidaemia, insulin resistance, hypertension, central obesity, accelerated atherosclerosis) but also provides a mechanism for many other abnormalities seen in Type II diabetes, including those in blood clotting, the reproductive system, metal ion metabolism, psychological behaviour and capillary permeability. In the short-term, the innate immune system restores homeostasis after environmental threats; we suggest that in Type II diabetes and impaired glucose tolerance long-term lifestyle and environmental stimulants, probably in those with an innately hypersensitive acute-phase response, produce disease instead of repair.
Comment in
-
The role of cytokines of the innate and adaptive immune system in the regulation of insulin resistance.Diabetologia. 1999 Apr;42(4):497-8. doi: 10.1007/s001250051187. Diabetologia. 1999. PMID: 10230657 No abstract available.
Similar articles
-
The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.Med Hypotheses. 2006;67(4):879-91. doi: 10.1016/j.mehy.2006.04.008. Epub 2006 Jun 15. Med Hypotheses. 2006. PMID: 16781084
-
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.Diabetologia. 2002 Jun;45(6):805-12. doi: 10.1007/s00125-002-0829-2. Epub 2002 May 8. Diabetologia. 2002. PMID: 12107724
-
Innate immunity, insulin resistance and type 2 diabetes.Trends Endocrinol Metab. 2008 Jan;19(1):10-6. doi: 10.1016/j.tem.2007.10.004. Epub 2007 Dec 21. Trends Endocrinol Metab. 2008. PMID: 18082417 Review.
-
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.Diabetologia. 1997 Nov;40(11):1286-92. doi: 10.1007/s001250050822. Diabetologia. 1997. PMID: 9389420
-
Lifestyle modification and endothelial function in obese subjects.Expert Rev Cardiovasc Ther. 2005 Mar;3(2):231-41. doi: 10.1586/14779072.3.2.231. Expert Rev Cardiovasc Ther. 2005. PMID: 15853597 Review.
Cited by
-
Metabolic syndrome and inflammation: a critical review of in vitro and clinical approaches for benefit assessment of plant food supplements.Evid Based Complement Alternat Med. 2013;2013:782461. doi: 10.1155/2013/782461. Epub 2013 Feb 27. Evid Based Complement Alternat Med. 2013. PMID: 23533519 Free PMC article.
-
Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study.Metabolites. 2024 Jun 30;14(7):371. doi: 10.3390/metabo14070371. Metabolites. 2024. PMID: 39057694 Free PMC article.
-
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.J Am Soc Nephrol. 2012 Mar;23(3):507-15. doi: 10.1681/ASN.2011060627. Epub 2012 Jan 19. J Am Soc Nephrol. 2012. PMID: 22266663 Free PMC article.
-
U shape association between triglyceride glucose index and congestive heart failure in patients with diabetes and prediabetes.Nutr Metab (Lond). 2024 Jul 2;21(1):42. doi: 10.1186/s12986-024-00819-7. Nutr Metab (Lond). 2024. PMID: 38956581 Free PMC article.
-
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.Diabetes Care. 2022 Nov 1;45(11):2644-2652. doi: 10.2337/dc22-0866. Diabetes Care. 2022. PMID: 36134918 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials